Persistent chylothorax associated with lymphatic malformation type 6 due to biallelic pathogenic variants in PIEZO1

Am J Med Genet A. 2023 Aug;191(8):2188-2192. doi: 10.1002/ajmg.a.63237. Epub 2023 May 9.

Abstract

PIEZO1 is required for lymphatic valve formation, and several lymphatic abnormalities have been reported to be associated with autosomal recessive PIEZO1 pathogenic variants including neonatal hydrops, lymphedema involving various body regions, and chylothorax. Persistent or recurrent chylothorax has been infrequently described in association with pathogenic variants in the PIEZO1 gene. We present a 4-year-old female with bilateral pleural effusions detected prenatally, who was diagnosed with bilateral chylothoraces post-partum. She subsequently had recurrent pleural effusions involving both pleural cavities, which tended to improve with restriction of her fat intake, and, one occasion, subcutaneous octreotide. She also had bilateral calf, and intermittent cheek swelling. Genetic testing revealed two deleterious variants in PIEZO1: c.2330-2_2330-1del and c.3860G > A (p.Trp1287*), both of which were classified as likely pathogenic. This supported a diagnosis of Lymphatic Malformation Type 6 (OMIM 616843), also known as Hereditary Lymphedema Type III. Hereditary Lymphedema type III can be associated with persistent chylothorax that can vary in size over time.

Keywords: PIEZO1 protein; chylothorax; congenital; genetic diseases; human; inborn; lymphedema.

Publication types

  • Case Reports

MeSH terms

  • Child, Preschool
  • Chylothorax* / diagnosis
  • Chylothorax* / genetics
  • Female
  • Humans
  • Infant, Newborn
  • Ion Channels / genetics
  • Lymphangiogenesis
  • Lymphedema* / complications
  • Lymphedema* / diagnosis
  • Lymphedema* / genetics
  • Pleural Effusion*

Substances

  • PIEZO1 protein, human
  • Ion Channels